【摘要】：正全球臨床試驗注冊制度由世界各國政府共同決定由WHO領(lǐng)導(dǎo)建立。臨床試驗注冊具有倫理和科學(xué)的雙重意義,目的是為了尊重和珍惜所有試驗參與者的貢獻(xiàn),他們的貢獻(xiàn)用于改善全社會的醫(yī)療保健,因此,任何臨床試驗都與公眾利益相關(guān)。公開臨床試驗的信息,并將其置于公眾監(jiān)督之下是試驗研究者的義務(wù)和道德責(zé)任。臨床試驗注冊不僅能確保追溯每個臨床試驗的結(jié)果,公開在研試驗或試驗結(jié)果信息還有助于減少不必要的重復(fù)研究。
[Abstract]:The global clinical trial registration system is jointly decided by governments around the world and led by WHO. Clinical trial registration is of both ethical and scientific significance in order to respect and value the contributions of all participants, whose contributions are used to improve health care throughout society. Therefore, any clinical trial is in the public interest. It is the duty and moral responsibility of the trial researchers to make public information about clinical trials and place them under public supervision. Clinical trial registration not only ensures that the results of each clinical trial are traced, but that disclosure of information on the results of ongoing trials or trials also helps to reduce unnecessary duplication of research.
【分類號】：+

【相似文獻(xiàn)】

相關(guān)期刊論文 前2條

1 本刊編輯部;;凡臨床試驗都應(yīng)在中國臨床試驗注冊中心注冊[J];中國腫瘤生物治療雜志;2014年03期

2 本刊編輯部;;凡臨床試驗都應(yīng)在中國臨床試驗注冊中心注冊[J];中國腫瘤生物治療雜志;2014年04期

，

本文編號：2206732